A Randomized, Open-label, Single Dose, 3x3 Partial Replicated Crossover Study to Evaluate the Pharmacokinetics and Safety/Tolerability Between a Fixed Dose Combination of Fimasartan/Amlodipine and Co-administration of Fimasartan and Amlodipine in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 24 Mar 2018
At a glance
- Drugs Amlodipine/fimasartan (Primary) ; Amlodipine; Fimasartan
- Indications Essential hypertension
- Focus Pharmacokinetics
- Sponsors Boryung Pharmaceutical
- 24 Mar 2018 Results (n=56) presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 25 Nov 2016 Status changed from not yet recruiting to recruiting.
- 03 Oct 2016 New trial record